Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Insmed Incorporated

Clinical trials sponsored by Insmed Incorporated, explained in plain language.

Insmed INSM NASDAQ

A biopharmaceutical company focused on serious rare diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 2 Completed 7 Terminated 1

New hope for painful skin condition: brensocatib enters phase 2b trial

Disease control Terminated

This study tests whether brensocatib can reduce painful lumps and abscesses in people with moderate to severe hidradenitis suppurativa (HS). About 214 adults will receive either brensocatib or a placebo for 16 weeks. The goal is to see if the drug improves skin lesions and overal…

Phase: PHASE2 • Sponsor: Insmed Incorporated • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC